Lexaria Bioscience Corp. — Form D

Lexaria Bioscience Corp. of KELOWNA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-19. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Nicholas BaxterDirectorKelowna, A1
Bal Edward BhullarDirectorKelowna, A1
Christopher BunkaDirectorKelowna, A1
Richard ChristopherDirectorKelowna, A1
John DochertyDirectorKelowna, A1
William Edward McKechnieDirectorKelowna, A1
ALBERT Edward REESEDirectorKelowna, A1
Richard ChristopherExecutive OfficerKelowna, A1
John DochertyExecutive OfficerKelowna, A1
Michael ShankmanExecutive OfficerKelowna, A1
Christopher BunkaExecutive OfficerKelowna, A1
Allan SpissingerExecutive OfficerKelowna, A1
Brian QuigleyDirectorRichmond, VA
CATHERINE TURKELDirectorKelowna, A1
ALBERT REESEDirectorKelowna, A1
TED MCKECHNIEDirectorKelowna, A1
Nelson CabatuanExecutive OfficerKelowna, A1
Nicholas W BaxterDirectorVancouver, A1
GREGORY DOWNEYExecutive OfficerKelowna, A1
CHRIS BUNKADirectorKelowna, A1
CHRIS BUNKAExecutive OfficerKelowna, A1
John Martin DochertyDirectorKelowna, A1
John Martin DochertyExecutive OfficerKelowna, A1
Ted W McKechnieDirectorKitchener, A6
Allan W SpissingerExecutive OfficerKelowna, A1

Other filings by this issuer (13)

FiledFormOfferingSold
2025-10-01D$4.0M$4.0M
2024-10-16D$5.0M$5.0M
2024-05-02D$365K$365K
2024-02-16D$3.6M$3.6M
2023-10-04D$1.6M$1.6M
2021-12-20D$1.2M$1.2M
2021-07-27D$85K$85K
2020-07-08D$100K$100K
2020-05-13D$2.0M$2.0M
2019-11-19D$2.4M$493K
2019-11-13D$180K$180K
2018-11-15D$310K$310K
2016-09-13D$109K$109K

More